Tenet Healthcare (THC) reported $5.22 billion in revenue for the quarter ended March 2025, representing a year-over-year decline of 2.7%. EPS of $4.36 for the same period compares to $3.22 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $5.14 billion, representing a surprise of +1.64%. The company delivered an EPS surprise of +40.19%, with the consensus EPS estimate being $3.11.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Tenet performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Adjusted admissions: 213.04 thousand versus 223.59 thousand estimated by two analysts on average.
- Net Operating revenues: $5.22 billion versus the four-analyst average estimate of $5.15 billion. The reported number represents a year-over-year change of -2.7%.
- Net Operating revenues- Ambulatory Care: $1.19 billion compared to the $1.12 billion average estimate based on three analysts. The reported number represents a change of +20% year over year.
- Net Operating revenues- Hospital Operations and Services: $4.03 billion compared to the $4.02 billion average estimate based on three analysts. The reported number represents a change of -7.9% year over year.
- Adjusted EBITDA- Hospital Operations and Services: $707 million compared to the $551.31 million average estimate based on four analysts.
- Equity in earnings of unconsolidated affiliates: $56 million compared to the $61.07 million average estimate based on four analysts.
- Adjusted EBITDA- Ambulatory Care: $456 million versus $437.28 million estimated by two analysts on average.
View all Key Company Metrics for Tenet here>>>
Shares of Tenet have returned -7.9% over the past month versus the Zacks S&P 500 composite's -0.8% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Tenet Healthcare Corporation (THC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
